Home > Research > Publications & Outputs > Costs of illness and care in Parkinson's disease
View graph of relations

Costs of illness and care in Parkinson's disease: an evaluation in six countries

Research output: Contribution to Journal/MagazineJournal articlepeer-review

  • Sonja von Campenhausen
  • Yaroslav Winter
  • Antonio Rodrigues e Silva
  • Christina Sampaio
  • Evzen Ruzicka
  • Paolo Barone
  • Werner Poewe
  • Alla Guekht
  • Ceu Mateus
  • Karl-P. Pfeiffer
  • Karin Berger
  • Jana Skoupa
  • Kai Bötzel
  • Sabine Geiger-Gritsch
  • Uwe Siebert
  • Monika Balzer-Geldsetzer
  • Wolfgang H. Oertel
  • Richard Dodel
  • Jens P. Reese
<mark>Journal publication date</mark>02/2011
<mark>Journal</mark>European Neuropsychopharmacology
Issue number2
Number of pages12
Pages (from-to)180-191
Publication StatusPublished
Early online date2/10/10
<mark>Original language</mark>English


We investigated the costs of Parkinson's Disease (PD) in 486 patients based on a survey conducted in six countries. Economic data were collected over a 6-month period and presented from the societal perspective. The total mean costs per patient ranged from EUR 2620 to EUR 9820. Direct costs totalled about 60% to 70% and indirect costs about 30% to 40% of total costs. The proportions of costs components of PD vary notably; variations were due to differences in country-specific health system characteristics, macro economic conditions, as well as frequencies of resource use and price differences. However, inpatient care, long-term care and medication were identified as the major expenditures in the investigated countries.